Menthol Cough Suppressant Oral Anesthetic Cough Drops

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to a cold and for the alleviation of occasional minor irritation, pain, sore mouth, and sore throat.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is advised to consult a doctor before administration.

Contraindications

Use of this product is contraindicated in situations where it may be accessible to children, as there is a risk of accidental ingestion. It is essential to ensure that this and all medications are stored securely out of the reach of children to prevent potential harm. No other specific contraindications have been identified.

Warnings and Precautions

Patients should be advised to seek medical attention if they experience a severe sore throat that persists for more than two days, particularly if it is accompanied by fever, headache, rash, swelling, nausea, or vomiting. These symptoms may indicate a more serious underlying condition that requires prompt evaluation.

Healthcare professionals should instruct patients to consult a physician prior to using this product if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema. Additionally, patients with a cough that is accompanied by excessive phlegm (mucus) should also seek medical advice before use.

During the use of this product, it is imperative that patients adhere strictly to the recommended dosage. Exceeding the advised dosage may lead to adverse effects.

Patients must discontinue use and consult a healthcare provider if any of the following occur: a cough that persists for more than one week, a cough that tends to recur, or a cough accompanied by fever, rash, or persistent headache. Such symptoms may indicate a serious condition that warrants further investigation. Furthermore, if sore mouth symptoms do not show improvement within seven days, or if irritation, pain, or redness persists or worsens, patients should seek medical advice promptly.

Side Effects

Patients may experience a range of adverse reactions while using the medication. Serious adverse reactions include severe sore throat, which, if it persists for more than 2 days or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, necessitates prompt consultation with a healthcare provider.

Additionally, patients should discontinue use and seek medical advice if they experience a cough that persists for more than 1 week, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Other notable adverse reactions include sore mouth symptoms that do not improve within 7 days, as well as any irritation, pain, or redness that persists or worsens. It is essential for patients to monitor these symptoms closely and communicate with their healthcare provider as needed.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Menthol Cough Suppressant Oral Anesthetic Cough Drops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older are instructed to dissolve the lozenge slowly in the mouth and may repeat the dosage every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, consultation with a doctor is advised prior to use.

It is important to note that the lozenge presents a choking hazard due to small parts for children under 4 years of age. Therefore, children should always be seated and supervised while consuming the lozenge to minimize the risk of choking.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, the safety concerns, dosage modifications, or special precautions for pregnant patients remain undefined. Healthcare professionals should exercise caution when prescribing this product to women of childbearing potential and consider the lack of information when assessing the potential risks and benefits for pregnant patients. It is advisable to monitor any emerging data related to fetal outcomes as it becomes available.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or relevant toxicology resources for guidance on management strategies tailored to the specific circumstances of the overdosage event.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children. It is essential to emphasize the importance of proper storage to prevent accidental ingestion or misuse. Patients should be informed about the potential risks associated with leaving medications accessible to children and encouraged to take necessary precautions to ensure safety.

Storage and Handling

The product is supplied in a configuration that includes a primary bag, which must be inspected prior to use. It is essential to ensure that the primary bag seal is intact; do not use the product if the seal has been torn or broken.

Storage conditions require that the product be kept at room temperature. It should be protected from excessive heat and direct sunlight to maintain its integrity and efficacy. Proper handling and storage are crucial to ensure the product remains safe for use.

Additional Clinical Information

For patients aged 2 years and older, the recommended administration involves dissolving the lozenge slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is advised to consult a doctor before use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Menthol Cough Suppressant Oral Anesthetic Cough Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)